CRVS लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:36):
Our systems believe the stock currently is undervalued by 0.25% compare to its pairs and should correct upwards.

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies...

Stats
आज की मात्रा	13 109
औसत मात्रा	230 496
बाजार मूल्य	112.59M
EPS	$-0.120 ( Q1 \| 2024-05-07 )
अगली कमाई की तारीख	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.53 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0110 (0.61%)

AADI -2.65%

ABCL 1.47%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.64%

ABSI 3.07%

ABUS -2.29%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.12%

ACGN 1.29%

ACHL -3.00%

ACHV -1.72%

ACIU -1.00%

ACLX -0.04%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.68%

ADPT -0.30%

ADTX -3.47%

ADVM -3.91%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.58%

AGIO -2.04%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.46%

AKRO -2.89%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -2.29%

ALGS -2.41%

ALKS -0.19%

ALLK -9.28%

ALLO -6.24%

ALLR -3.32%

ALNA 3.16%

ALNY 1.82%

ALPN 0.02%

ALPX 0.00%

ALRN -0.33%

ALT -9.51%

ALVR -0.56%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.46%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.66%

ANPC -3.15%

APGE -0.91%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.00%

APLT -5.41%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.84%

ARDS -14.23%

ARDX -0.75%

ARGX -0.81%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.63%

ARWR -1.71%

ASLN -4.71%

ASMB -7.14%

ASND -0.94%

ATAI -1.11%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.74%

ATRA -3.22%

ATXI 1.93%

ATXS -0.89%

AUPH -1.17%

AURA 1.17%

AUTL -1.72%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.19%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.99%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.90%

BCAB 2.28%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.23%

BCTX 7.65%

BCTXW -17.37%

BCYC 1.10%

BDRX -3.52%

BDTX -0.85%

BEAM 0.45%

BFRA -2.91%

BGNE -2.72%

BIOR -3.40%

BIVI 1.26%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.52%

BMEA -9.98%

BMRN 0.36%

BNOX -2.22%

BNTC -2.11%

BNTX -1.55%

BOLD -7.90%

BOLT 1.31%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 23.31%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.48%

CADL -1.05%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.89%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 5.52%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.99%

CERO -3.40%

CEROW -10.18%

CFRX -27.95%

CGEM -2.50%

CGEN -3.31%

CGON -0.48%

CGTX -5.11%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.87%

CLBS -16.75%

CLDX -2.26%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.04%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -39.44%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.83%

CORT 2.20%

COYA -1.46%

CPRX -0.99%

CRBP -1.88%

CRBU -4.91%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.86%

CRSP 0.97%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -2.49%

CTNM -0.65%

CTXR 1.46%

CUE 3.61%

CVAC -2.26%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 9.75%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.08%

CYTO -2.73%

DARE 6.41%

DAWN 0.75%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 30.67%

DNLI -1.70%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.41%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.98%

ELOX 7.69%

ELTX -0.88%

ELVN -3.87%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.13%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -1.02%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.03%

EXAI -0.76%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.12%

FATE -7.53%

FBIO 0.59%

FBIOP 0.92%

FBLG -14.34%

FBRX -0.04%

FDMT -4.64%

FENC -0.97%

FGEN -5.13%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.68%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.31%

FULC -3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -5.89%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.31%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -8.92%

GOVX 5.93%

GOVXW -49.04%

GPCR -6.50%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.33%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -1.05%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.77%

HOOK 0.80%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 2.30%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -3.99%

ICCC 0.22%

ICPT 0.21%

ICU 16.82%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.95%

IFRX -1.85%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.72%

INAB 0.00%

INBX 0.46%

INCY -0.84%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 3.01%

INO -1.95%

INSM -0.81%

INTS -2.75%

INVA 0.25%

INZY 0.92%

IOBT -11.42%

IONS 0.34%

IOVA -2.37%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.54%

ISEE 0.38%

ITOS -1.50%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.05%

JANX -4.02%

JAZZ -0.60%

JNCE 0.00%

JSPR -6.11%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.95%

KDNY 0.22%

KMPH -0.34%

KNSA -2.84%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -1.05%

KTRA 17.29%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.41%

KYTX -4.52%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.60%

LENZ -3.36%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.52%

LPCN -4.05%

LPTX -1.10%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -35.05%

LYRA 2.33%

MACK 0.10%

MBIO -9.29%

MBRX -1.72%

MCRB 2.31%

MDGL -2.52%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.97%

MGX -2.68%

MIRM -1.54%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.79%

MNKD -1.14%

MNMD 0.14%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.18%

MORF -3.77%

MREO -6.56%

MRKR 2.68%

MRNA -4.88%

MRNS -4.04%

MRSN -2.40%

MRTX -0.17%

MRUS 0.13%

MRVI -1.97%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.15%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.90%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -0.91%

NMTR -42.97%

NOVN -24.84%

NRBO 10.16%

NRIX -0.34%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.07%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -2.49%

OBSV 0.00%

OCEA 0.00%

OCGN 4.24%

OCS -1.02%

OCUL -2.29%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.54%

OMER -1.03%

OMGA 5.00%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.44%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.99%

PBYI 1.69%

PCSA 0.00%

PCVX -0.43%

PDSB -2.05%

PEPG 0.27%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.07%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.00%

PRQR -0.01%

PRTA -2.45%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -0.97%

PTCT -0.28%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.95%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.10%

RCKT -7.81%

REGN -0.70%

RENB -3.41%

REPL -2.49%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.44%

RIGL -3.28%

RLAY -4.68%

RLMD 0.33%

RLYB -0.34%

RNA -0.42%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.12%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.00%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -1.13%

RVMDW -30.00%

RVNC 2.13%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.51%

RYZB 0.02%

RZLT 1.68%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.06%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.51%

SCPS 0.00%

SEEL -4.48%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.05%

SLGL 4.00%

SLN -4.21%

SLNO -4.03%

SLRX 6.69%

SLS -2.58%

SMMT -2.75%

SNDX 0.84%

SNGX -4.52%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.59%

SRRA 0.00%

SRRK -2.79%

SRZN -2.45%

STAB 0.00%

STOK -5.09%

STRO -2.84%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.16%

SWTX 0.27%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.57%

TARS 0.06%

TBPH 0.60%

TCBP 2.73%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.15%

TENX -1.27%

TERN -7.72%

TFFP -3.05%

TGTX -2.97%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -6.39%

TNYA -7.18%

TPST 2.87%

TRDA -3.86%

TRVI 1.15%

TRVN 2.92%

TSHA -24.24%

TSVT -3.19%

TTNP -9.27%

TVTX 0.63%

TYRA -7.09%

UBX -2.12%

UNCY -2.43%

URGN -1.15%

UTHR -0.32%

VACC 11.36%

VALN -2.89%

VAXX 106.32%

VBIV 0.78%

VBLT -8.77%

VCEL 0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.74%

VERU 0.78%

VERV -3.06%

VIGL 5.11%

VINC 1.62%

VIR 0.43%

VIRI -1.57%

VIRX 2.40%

VKTX -1.72%

VLON -13.04%

VNDA -2.28%

VOR -2.02%

VRCA -0.07%

VRDN -4.15%

VRNA -1.40%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.59%

VYGR -1.53%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.61%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -2.81%

XERS 2.86%

XFOR 2.86%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.57%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.51%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-13	Grais Linda	Buy	15 000	Stock Option (Right to Buy)
2024-06-13	Clark Ian T	Buy	15 000	Stock Option (Right to Buy)
2024-06-13	Morrison Scott W	Buy	15 000	Stock Option (Right to Buy)
2024-06-13	Gould Terry P	Buy	15 000	Stock Option (Right to Buy)
2024-06-13	Thompson Peter A.	Buy	15 000	Stock Option (Right to Buy)

INSIDER POWER
93.20
Last 98 transactions
Buy: 11 774 084 \| Sell: 7 521 304

सहसंबंध (AI algo v.1.1b): Undervalued: 0.25% $1.805 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: -0.06 (neutral)

छोटा: 0.32 (neutral)

Signal:(47.639) Neutral

Corvus Pharmaceuticals सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
OZEM	1
VRSK	0.818
HSTM	0.817
FNKO	0.813
MMSI	0.802

10 सबसे अधिक नकारात्मक सहसंबंध
ISUN	-0.827
ASTE	-0.808

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Corvus Pharmaceuticals सहसंबंध - मुद्रा/वस्त्र

0.04
( neutral )

0.37
( neutral )

0.00
( neutral )

0.75
( moderate )

0.00
( neutral )

-0.14
( neutral )

Corvus Pharmaceuticals वित्तीय

Annual	2023
राजस्व:	$0
सकल लाभ:	$-151 000 (0.00 %)
EPS:	$-0.560

FY	2023
राजस्व:	$0
सकल लाभ:	$-151 000 (0.00 %)
EPS:	$-0.560

FY	2022
राजस्व:	$0
सकल लाभ:	$-367 000 (0.00 %)
EPS:	$-1.080

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.030

Financial Reports:

No articles found.

Corvus Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Corvus Pharmaceuticals

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with either advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines. The company was incorporated in 2014 and is based in Burlingame, California.